Search research articles
Contact Us
Filters
Showing results (431-440 of 683) with videos related to
Page
of 69
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2006
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes
José G Guillem, William C Wood, Jeffrey F Moley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2007
An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer
Holly K Dressman, Andrew Berchuck, Gina Chan, et al.
Gynecologic Oncology Reports
|
June 16, 2025
A pilot study investigating the effect of pembrolizumab on the tumoral immunoprofile of newly diagnosed mullerian cancers
Stéphanie L Gaillard, Gloria Broadwater, Andrew Berchuck, et al.
Frontiers in Genetics
|
March 31, 2012
Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian Carcinoma
Linda E Kelemen, Qinggang Wang, Irina Dinu, et al.
European Journal of Gynaecological Oncology
|
February 24, 2001
Conseusus statements on prognostic factors in epithelial ovarian carcinoma. Report of the Consensus Meeting organized by the European Society of Gynaecological Oncology, ESGO
P Bösze, R C Bast, A Berchuck, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
Homologous recombination deficiency in ovarian high-grade serous carcinoma by self-reported race
Katherine A Lawson-Michod, Courtney E Johnson, Mollie E Barnard, et al.
International Journal of Cancer
|
September 25, 2020
Evaluating the role of alcohol consumption in breast and ovarian cancer susceptibility using population-based cohort studies and two-sample Mendelian randomization analyses
Jue-Sheng Ong, Eske M Derks, Mikael Eriksson, et al.
The Oncologist
|
August 13, 2022
Concordance Between Genomic Alterations Detected by Tumor and Germline Sequencing: Results from a Tertiary Care Academic Center Molecular Tumor Board
Michelle F Green, Catherine H Watson, Sarah Tait, et al.
Nature Medicine
|
October 24, 2006
Genomic signatures to guide the use of chemotherapeutics
Anil Potti, Holly K Dressman, Andrea Bild, et al.
Nature Medicine
|
January 11, 2011
Retraction: Genomic signatures to guide the use of chemotherapeutics
Anil Potti, Holly K Dressman, Andrea Bild, et al.
Page
of 69
Search research articles
Search
Showing results (431-440 of 683) with videos related to
Sort By:
Page
of 69
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2006
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes
José G Guillem, William C Wood, Jeffrey F Moley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2007
An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer
Holly K Dressman, Andrew Berchuck, Gina Chan, et al.
Gynecologic Oncology Reports
|
June 16, 2025
A pilot study investigating the effect of pembrolizumab on the tumoral immunoprofile of newly diagnosed mullerian cancers
Stéphanie L Gaillard, Gloria Broadwater, Andrew Berchuck, et al.
Frontiers in Genetics
|
March 31, 2012
Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian Carcinoma
Linda E Kelemen, Qinggang Wang, Irina Dinu, et al.
European Journal of Gynaecological Oncology
|
February 24, 2001
Conseusus statements on prognostic factors in epithelial ovarian carcinoma. Report of the Consensus Meeting organized by the European Society of Gynaecological Oncology, ESGO
P Bösze, R C Bast, A Berchuck, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
Homologous recombination deficiency in ovarian high-grade serous carcinoma by self-reported race
Katherine A Lawson-Michod, Courtney E Johnson, Mollie E Barnard, et al.
International Journal of Cancer
|
September 25, 2020
Evaluating the role of alcohol consumption in breast and ovarian cancer susceptibility using population-based cohort studies and two-sample Mendelian randomization analyses
Jue-Sheng Ong, Eske M Derks, Mikael Eriksson, et al.
The Oncologist
|
August 13, 2022
Concordance Between Genomic Alterations Detected by Tumor and Germline Sequencing: Results from a Tertiary Care Academic Center Molecular Tumor Board
Michelle F Green, Catherine H Watson, Sarah Tait, et al.
Nature Medicine
|
October 24, 2006
Genomic signatures to guide the use of chemotherapeutics
Anil Potti, Holly K Dressman, Andrea Bild, et al.
Nature Medicine
|
January 11, 2011
Retraction: Genomic signatures to guide the use of chemotherapeutics
Anil Potti, Holly K Dressman, Andrea Bild, et al.
Page
of 69